Lidocaine Hci And Epinephrine Injection, Solution
Product Images NDC 51662-1506

15 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci And Epinephrine (NDC 51662-1506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00351662150627 Xylocaine Pouch Label

00351662150627 Xylocaine Pouch Label
Label for Lidocaine HCl and Epinephrine injection, solution, branded as Xylocaine with Epi 1:100,000, containing 400 mg per 20 mL vial (20 mg/mL). The label includes the NDC 51662-1506-2, lot number, expiration date, and storage instructions. Manufactured by HF Acquisition Co, LLC, Mukilteo, WA.*
FDA Label Image

00351662150634 Xylocaine Rfid Label

00351662150634 Xylocaine Rfid Label
A small label containing a GS1 DataMatrix barcode and GTIN (00351662150634) for LIDOCAINE HCl AND EPINEPHRINE injection solution. The label includes batch number (12345), expiration date (250101), and a serial number (189907261163). It states distribution by HF Acquisition Co., LLC in Mukilteo, WA, and indicates RX only.*
FDA Label Image

00351662150634 Xylocaine Case Label

00351662150634 Xylocaine Case Label
Label for XYLOCAINE with epinephrine 1:100,000 2% 400 mg per 20 mL (20 mg/mL) injection solution vial, box of 25. NDC 51662-1506-3, lot 12345, expiration date 2025-01-01. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Instructions indicate use for infiltration and nerve block, not for caudal or epidural use, and storage between 20°C and 25°C.*
FDA Label Image

51662-1506-1 20 mL Multidose Serialized Vial Labeling (51662 1506 1 20 mL Serialized Vial Labeling)

51662-1506-1 20 mL Multidose Serialized Vial Labeling (51662 1506 1 20 mL Serialized Vial Labeling)
Lidocaine HCl and Epinephrine injection, solution in a clear glass vial with a red cap. The label identifies the product as Xylocaine, containing 2% lidocaine with epinephrine 1:100,000, 400 mg per 20 mL multiple dose vial. It is labeled for infiltration and nerve block use, distributed by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

51662-1506-1 20 mL Multidose Vial Label (51662 1506 1 20 mL Vial Label)

51662-1506-1 20 mL Multidose Vial Label (51662 1506 1 20 mL Vial Label)
Label for Xylocaine (lidocaine HCl and epinephrine injection, USP) with epinephrine 1:100,000. It is a 2% solution with 400 mg per 20 mL (20 mg/mL) in a 20 mL multiple dose vial. The label includes usage instructions for infiltration and nerve block, with a caution against caudal or epidural use. Manufactured by Fresenius Kabi.*
FDA Label Image

Dosage Rec 1 (Dosage Rec Part 1)

Dosage Rec 1 (Dosage Rec Part 1)
A table titled 'Recommended Dosages' listing various infiltration procedures for Xylocaine (lidocaine hydrochloride) injection without epinephrine. The table details concentration percentages, volume ranges in milliliters, and total dose ranges in milligrams for procedures including percutaneous, intravenous regional, and several types of peripheral nerve blocks such as brachial, dental, intercostal, paravertebral, pudendal, and paracervical blocks.*
FDA Label Image

Dosage Rec 2 (Dosage Rec Part 2)

Dosage Rec 2 (Dosage Rec Part 2)
A data table presenting dosage information related to various nerve blocks and anesthesia types, including obstetrical analgesia, sympathetic nerve blocks, cervical and lumbar blocks, epidural, thoracic, caudal, and surgical anesthesia. The table includes dosage amounts for each category with notes on determining dose by dermatomes where applicable.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
A data table listing various product codes, unit of sale with NDC numbers, strengths, and packaging details for Xylocaine (lidocaine HCl Injection, USP). The table includes concentrations ranging from 0.5% to 2% with vial sizes and multiple dose vial designations.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
A data table titled 'Xylocaine - MPF (Lidocaine HCl Injection, USP)' listing various product codes, units of sale, strengths, and packaging details for different lidsocaine HCl injection formulations. Strengths range from 0.5% to 2%, with corresponding vial or ampule sizes such as 2 mL, 5 mL, 10 mL, 20 mL, and 30 mL single-dose vials or plastic ampules.*
FDA Label Image

How Supplied 3 (How Supplied 3)

How Supplied 3 (How Supplied 3)
Data tables listing multiple strengths and package sizes of Xylocaine (lidocaine HCl and epinephrine injection, USP) with concentrations of epinephrine 1:100,000 and 1:200,000. The tables include product codes, NDC unit of sale codes, strength specifications in mg and percentage, and descriptions of vial sizes ranging from 10 mL to 50 mL multiple-dose vials.*
FDA Label Image

How Supplied 4 (How Supplied 4)

How Supplied 4 (How Supplied 4)
A data table listing multiple product codes, units of sale, strengths, and package forms for Xylocaine -MPF (lidocaine HCl and epinephrine injection, USP) with epinephrine 1:200,000. The table includes NDC numbers, vial sizes (10 mL to 30 mL), concentration percentages (1%, 1.5%, 2%), and single-dose vial packaging details.*
FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table listing drug classes in one column and examples of drugs in each class in the adjacent column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as lidocaine under Local anesthetics and acetaminophen under Other drugs.*
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure diagram of lidocaine hydrochloride, showing its molecular components and arrangement as part of the LIDOCAINE HCI AND EPINEPHRINE product.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure diagram of epinephrine, an active ingredient in Lidocaine HCl and Epinephrine injection solution. The diagram displays the molecular components and bonds characteristic of epinephrine's chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.